BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wagner M, Schilling R, Doeblin P, Huppertz A, Luhur R, Schwenke C, Maurer M, Hamm B, Taupitz M, Durmus T. Macrocyclic contrast agents for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison of gadobutrol and gadoterate meglumine. Eur Radiol 2013;23:108-14. [DOI: 10.1007/s00330-012-2563-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Rahsepar AA, Ghasemiesfe A, Suwa K, Dolan RS, Shehata ML, Korell MJ, Naresh NK, Markl M, Collins JD, Carr JC. Comprehensive evaluation of macroscopic and microscopic myocardial fibrosis by cardiac MR: intra-individual comparison of gadobutrol versus gadoterate meglumine. Eur Radiol 2019;29:4357-67. [DOI: 10.1007/s00330-018-5956-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
2 van der Molen AJ. Diagnostic Efficacy of Gadolinium-Based Contrast Media. In: Thomsen HS, Webb JAW, editors. Contrast Media. Berlin: Springer Berlin Heidelberg; 2014. pp. 181-91. [DOI: 10.1007/174_2013_896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Jimenez Juan L, Crean AM, Wintersperger BJ. Late Gadolinium Enhancement Imaging in Assessment of Myocardial Viability. Radiologic Clinics of North America 2015;53:397-411. [DOI: 10.1016/j.rcl.2014.11.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 2.1] [Reference Citation Analysis]
4 François CJ, Hartung MP, Reeder SB, Nagle SK, Schiebler ML. MRI for acute chest pain: current state of the art. J Magn Reson Imaging 2013;37:1290-300. [PMID: 23589367 DOI: 10.1002/jmri.24173] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
5 Lim J, Park EA, Song YS, Lee W. Single-Dose Gadoterate Meglumine for 3T Late Gadolinium Enhancement MRI for the Assessment of Chronic Myocardial Infarction: Intra-Individual Comparison with Conventional Double-Dose 1.5T MRI. Korean J Radiol 2018;19:372-80. [PMID: 29713214 DOI: 10.3348/kjr.2018.19.3.372] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
6 Gutberlet M. [Cardiac magnetic resonance imaging: from imaging to diagnosis]. Radiologe 2013;53:1033-52. [PMID: 24231826 DOI: 10.1007/s00117-013-2533-2] [Reference Citation Analysis]
7 Doeblin P, Schilling R, Wagner M, Luhur R, Huppertz A, Hamm B, Taupitz M, Durmus T. Intraindividual comparison of T1 relaxation times after gadobutrol and Gd-DTPA administration for cardiac late enhancement imaging. Eur J Radiol 2014;83:660-4. [PMID: 24433640 DOI: 10.1016/j.ejrad.2013.12.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
8 Wildgruber M, Stadlbauer T, Rasper M, Hapfelmeier A, Zelger O, Eckstein HH, Halle M, Rummeny EJ, Huber AM. Single-dose gadobutrol in comparison with single-dose gadobenate dimeglumine for magnetic resonance imaging of chronic myocardial infarction at 3 T. Invest Radiol 2014;49:728-34. [PMID: 24872002 DOI: 10.1097/RLI.0000000000000076] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
9 Bulluck H, Hammond-Haley M, Weinmann S, Martinez-Macias R, Hausenloy DJ. Myocardial Infarct Size by CMR in Clinical Cardioprotection Studies: Insights From Randomized Controlled Trials. JACC Cardiovasc Imaging 2017;10:230-40. [PMID: 28279370 DOI: 10.1016/j.jcmg.2017.01.008] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 8.2] [Reference Citation Analysis]
10 Wintersperger BJ, Bamberg F, De Cecco CN. Cardiovascular Imaging: The Past and the Future, Perspectives in Computed Tomography and Magnetic Resonance Imaging. Invest Radiol 2015;50:557-70. [PMID: 25985464 DOI: 10.1097/RLI.0000000000000164] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 2.8] [Reference Citation Analysis]
11 Lancelot E, Froehlich J, Heine O, Desché P. Effects of gadolinium-based contrast agent concentrations (0.5 M or 1.0 M) on the diagnostic performance of magnetic resonance imaging examinations: systematic review of the literature. Acta Radiol 2016;57:1334-43. [DOI: 10.1177/0284185115590434] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Stillman AE, Oudkerk M, Bluemke DA, de Boer MJ, Bremerich J, Garcia EV, Gutberlet M, van der Harst P, Hundley WG, Jerosch-Herold M, Kuijpers D, Kwong RY, Nagel E, Lerakis S, Oshinski J, Paul JF, Slart RHJA, Thourani V, Vliegenthart R, Wintersperger BJ. Imaging the myocardial ischemic cascade. Int J Cardiovasc Imaging 2018;34:1249-63. [PMID: 29556943 DOI: 10.1007/s10554-018-1330-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
13 Liu D, Ma X, Liu J, Zhao L, Chen H, Xu L, Sun Z, Fan Z. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine. Int J Cardiovasc Imaging 2017;33:1191-200. [DOI: 10.1007/s10554-017-1101-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]